These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36180990)

  • 21. Linking the proteins--elucidation of proteome-scale networks using mass spectrometry.
    Pflieger D; Gonnet F; de la Fuente van Bentem S; Hirt H; de la Fuente A
    Mass Spectrom Rev; 2011; 30(2):268-97. PubMed ID: 21337599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability-based approaches in chemoproteomics.
    George AL; Dueñas ME; Marín-Rubio JL; Trost M
    Expert Rev Mol Med; 2024 Apr; 26():e6. PubMed ID: 38604802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass spectrometric approaches for characterizing bacterial proteomes.
    VerBerkmoes NC; Connelly HM; Pan C; Hettich RL
    Expert Rev Proteomics; 2004 Dec; 1(4):433-47. PubMed ID: 15966840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics in Drug Development: The Dawn of a New Era?
    Frantzi M; Latosinska A; Mischak H
    Proteomics Clin Appl; 2019 Mar; 13(2):e1800087. PubMed ID: 30724014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is targeted proteomics? A concise revision of targeted acquisition and targeted data analysis in mass spectrometry.
    Borràs E; Sabidó E
    Proteomics; 2017 Sep; 17(17-18):. PubMed ID: 28719092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of mass spectrometry in proteomics.
    Guerrera IC; Kleiner O
    Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass spectrometry-based proteomics: basic principles and emerging technologies and directions.
    Van Riper SK; de Jong EP; Carlis JV; Griffin TJ
    Adv Exp Med Biol; 2013; 990():1-35. PubMed ID: 23378000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical proteomics in drug discovery.
    Drewes G
    Methods Mol Biol; 2012; 803():15-21. PubMed ID: 22065215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics by mass spectrometry--go big or go home?
    Khan MF; Bennett MJ; Jumper CC; Percy AJ; Silva LP; Schriemer DC
    J Pharm Biomed Anal; 2011 Jun; 55(4):832-41. PubMed ID: 21382686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomics approaches for myeloid leukemia drug discovery.
    Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
    Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction to Proteomics Technologies.
    Lenz C; Dihazi H
    Methods Mol Biol; 2016; 1362():3-27. PubMed ID: 26519167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding communication patterns of the innate immune system by quantitative proteomics.
    Sukumaran A; Coish JM; Yeung J; Muselius B; Gadjeva M; MacNeil AJ; Geddes-McAlister J
    J Leukoc Biol; 2019 Dec; 106(6):1221-1232. PubMed ID: 31556465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometry-based proteomics: existing capabilities and future directions.
    Angel TE; Aryal UK; Hengel SM; Baker ES; Kelly RT; Robinson EW; Smith RD
    Chem Soc Rev; 2012 May; 41(10):3912-28. PubMed ID: 22498958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing cell biology through proteomics in space and time (PROSPECTS).
    Lamond AI; Uhlen M; Horning S; Makarov A; Robinson CV; Serrano L; Hartl FU; Baumeister W; Werenskiold AK; Andersen JS; Vorm O; Linial M; Aebersold R; Mann M
    Mol Cell Proteomics; 2012 Mar; 11(3):O112.017731. PubMed ID: 22311636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput proteomics.
    Zhang Z; Wu S; Stenoien DL; Paša-Tolić L
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():427-54. PubMed ID: 25014346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic drug target deconvolution by mass spectrometry-based technologies.
    Noberini R; Bonaldi T
    Nat Struct Mol Biol; 2019 Oct; 26(10):854-857. PubMed ID: 31582842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A proteome catalog of Drosophila melanogaster: an essential resource for targeted quantitative proteomics.
    Ahrens CH; Brunner E; Hafen E; Aebersold R; Basler K
    Fly (Austin); 2007; 1(3):182-6. PubMed ID: 18820430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass spectrometry-based protein identification in proteomics-a review.
    Noor Z; Ahn SB; Baker MS; Ranganathan S; Mohamedali A
    Brief Bioinform; 2021 Mar; 22(2):1620-1638. PubMed ID: 32047889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.
    Wang J; Gao L; Lee YM; Kalesh KA; Ong YS; Lim J; Jee JE; Sun H; Lee SS; Hua ZC; Lin Q
    Pharmacol Ther; 2016 Jun; 162():10-22. PubMed ID: 26808165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.